Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0812020160220040661
Korean Journal of Neurogastroenterology and Motility
2016 Volume.22 No. 4 p.661 ~ p.669
Prevalence of Irritable Bowel Syndrome?like Symptoms in Japanese Patients with Inactive Inflammatory Bowel Disease
Tomita Toshihiko

Kato Yu
Takimoto Mayu
Yamasaki Takahisa
Kondo Takashi
Kono Tomoaki
Tozawa Katsuyuki
Yokoyama Yoko
Ikehara Hisatomo
Ohda Yoshio
Oshima Tadayuki
Fukui Hirokazu
Tanaka Shigemi
Shima Masayuki
Watari Jiro
Miwa Hiroto
Abstract
Background/Aims: Few studies are available that have investigated the risk factors for overlapping irritable bowel syndrome (IBS)-like symptoms in patients with inactive inflammatory bowel disease (IBD). The present study has 3 objectives: (1) to assess the prevalence of IBS-like symptoms in Japanese patients with inactive IBD using Rome III criteria, (2) to examine the relationship of IBS-like symptoms to health related quality of life (HR-QOL), and (3) to investigate associations for developing IBS-like symptoms in patients with inactive IBD.

Methods: IBS-like symptoms were evaluated using the Rome III questionnaire for functional gastrointestinal disorders. HR-QOL and hospital anxiety and depression scale were evaluated.

Results: IBS-like symptoms were found in 17.5% (7/40) of patients with inactive ulcerative colitis, 27.1% (29/107) of patients with inactive Crohn¡¯s disease (CD), and 5.3% (23/438) of healthy control subjects. The QOL level was significantly lower and anxiety score was significantly higher in inactive CD patients with IBS-like symptoms than in those without such symptoms (P = 0.003, P = 0.009). Use of anti-anxiety drugs was associated with the presence of IBS symptoms (P = 0.045). HR-QOL score was lower and anxiety score was higher in patients with inactive ulcerative colitis, but the difference was not statistically significant.

Conclusions: The prevalence of IBS-like symptoms in inactive IBD patients was significantly higher than in healthy controls. Inactive CD patients with IBS-like symptoms has low QOL and anxiety; suggesting that anxiety may be associated with symptom development in such patients.
KEYWORD
Anxiety, Inflammatory bowel diseases, Irritable bowel syndrome, Quality of life
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø